MétaCan
Menu
Back to cohort
Record W3025373602 · doi:10.1038/s41523-020-0155-1

Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

2020· review· en· W3025373602 on OpenAlexaff
Jan Hudeček, Leonie Voorwerk, Maartje van Seijen, Iris Nederlof, Michiel de Maaker, José van den Berg, Koen Van de Vijver, Karolina Sikorska, Sylvia Adams, Sandra Demaria, Giuseppe Viale, Torsten O. Nielsen, Sunil Badve, Stefan Michiels, W. Fraser Symmans, Christos Sotiriou, David L. Rimm, Stephen M. Hewitt, Carsten Denkert, Sibylle Loibl, Sherene Loi, Giancarlo Pruneri, Deborah Dillon, Maggie C.U. Cheang, Andrew Tutt, Jacqueline A. Hall, Zuzana Kos, Roberto Salgado, Marleen Kok, Hugo M. Horlings, Aini Hyytiäinen, Akira I. Hida, Alastair Thompson, Alexis Lefevre, Alexander J. Lazar, Allen M. Gown, Anna Sapino, Anant Madabhushi, André Moreira, Andrea S. Richardson, Andrea Vingiani, Andrew H. Beck, Andrew M. Bellizzi, Ángel Guerrero, Anita Grigoriadis, Anna Ehinger, Ana C. Garrido-Castro, Anne Vincent-Salomon, Anne‐Vibeke Lænkholm, Ashish Sharma, Ashley Cimino‐Mathews, Ashok Srinivasan, Balázs Ács, Baljit Singh, Benjamin C. Calhoun, Benjamin Haibe-Kans, Benjamin Solomon, Bibhusal Thapa, Brad H. Nelson, Brandon D. Gallas, Carlos Castaneda, Carmen Ballesteros‐Merino, Carmen Criscitiello, Carolien Boeckx, Cécile Colpaert, Cecily Quinn, Chakra S. Chennubhotla, Charles Swanton, Cinzia Solinas, Crispin T. Hiley, Damien Drubay, Daniel Bethmann, David A. Moore, Denis Larsimont, Dhanusha Sabanathan, Dieter Peeters, Dimitrios Zardavas, Doris Höflmayer, Douglas B. Johnson, E. Aubrey Thompson, Edi Brogi, Edith A. Perez, Ehab A. ElGabry, Elisabeth Specht Stovgaard, Elizabeth F. Blackley, Elvire Roblin, Emily Reisenbichler, Enrique Bellolio, Eva Balslev, Ewa Chmielik, Fabien Gaire, Fabrice André, Fang‐I Lu, Farid Azmoudeh Ardalan, Federico Rojo, Tina Gruosso, Francesco Ciompi, Franklin Peale, Fred R. Hirsch, Frederick Klauschen, Frédérique Penault‐Llorca, Gabriela Acosta Haab, Gelareh Farshid, Gert Van den Eynden, Giuseppe Curigliano, Giuseppe Floris, Glenn Broeckx, Harmut Koeppen, Harry R. Haynes, Heather L. McArthur, Heikki Joensuu, Helena Olofsson, Huang‐Chun Lien, I‐Chun Chen, Ian A. Cree, Isabel Frahm, Iva Brčić, Jack Junjie Chan, James Ziai, Jane Brock, Jelle Wesseling, Jennifer M. Giltnane, Jennifer K. Kerner, Jeppe Thagaard, Jeremy Braybrooke, Jeroen van der Laak, Jérôme Lemonnier, Jiping Zha, Joana Ribeiro, Jochen K. Lennerz, Jodi M. Carter, Joel Saltz, Johan Hartman, Johannes A. Hainfellner, John Le Quesne, Jonathon W. Juco, Jorge S. Reis‐Filho, Joselyn Sanchez, Joseph A. Sparano, Joël Cucherousset, Juan Carlos Araya, Julien Adam, Justin M. Balko, Kai Saeger, Kalliopi P. Siziopikou, Karen Willard‐Gallo, Karsten E. Weber, Katherine L. Pogue–Geile, Keith E. Steele, Kenneth Emancipator, Khalid AbdulJabbar, Khalid El Bairi, Kim Blenman, Kimberly H. Allison, Konstanty Korski, Lajos Pusztai, Laura Comerma, Laurence Buisseret, Lee Cooper, Leming Shi, Loes Kooreman, Luciana Molinero, Mónica V. Estrada, Magali Lacroix‐Triki, Maise Al Bakir, Manu Sebastian, Marc J. van de Vijver, Marcelo Luiz Balancin, Maria Vittoria Dieci, Marie‐Christine Mathieu, Marlon C. Rebelatto, Martine Piccart, Matthew G. Hanna, Matthew P. Goetz, Matthias Preusser, Mehrnoush Khojasteh, Melinda E. Sanders, Meredith M. Regan, Michael Barnes, Michael Christie, Michael J. Misialek, Michail Ignatiadis, Mieke Van Bockstal, Miluska Castillo, Mohamed Amgad, Nadia Harbeck, Nadine Tung, Nele Laudus, Nicolas Sirtaine, Nicole Burchardi, Nils Ternès, Nina Radosevic‐Robin, Oleg Gluz, Oliver Grimm, Paolo Nucíforo, Paul Jank, Paula I. González-Ericsson, Pawan Kirtani, Petar Jelinic, Peter H. Watson, Peter Savas, Prudence A. Francis, Prudence A. Russell, Rim S. Kim, Robert H. Pierce, Robert K. Hills, Roberto A. Leon‐Ferre, Roland de Wind, Ruohong Shui, Sabine De Clercq, Sam Leung, Sami Tabbarah, Sandra C. Souza, Sandra A. O’Toole, Sandra M. Swain, Sarah Dudgeon, Scooter Willis, Scott Ely, Seong-Rim Kim, Shahinaz Bedri, Sheeba Irshad, Shiwei Liu, Shom Goel, Shona Hendry, Simonetta Bianchi, Sofia Bragança, Soonmyung Paik, Stephan Wienert, Stephen B. Fox, Stephen J. Luen, Stephen P. Naber, Stuart J. Schnitt, Luz F. Sua, Sunil R. Lakhani, Susan Fineberg, Teresa Soler, Thomas Gevaert, Timothy M. D’Alfonso, Tomohagu Sugie, Uday Kurkure, Veerle Bossuyt, Venkata Manem, Vincente Peg Cámara, Weida Tong, Weijie Chen, Wentao Yang, William T. Tran, Yihong Wang, Yinyin Yuan, Yves Allory, Zaheed Husain, Zsuzsanna Bagó-Horváth

Bibliographic record

Venuenpj Breast Cancer · 2020
Typereview
Languageen
FieldMedicine
TopicCancer Immunotherapy and Biomarkers
Canadian institutionsHealth Sciences CentreSunnybrook Health Science CentreBC Cancer AgencyPrincess Margaret Cancer CentreUniversity of OttawaOntario Institute for Cancer ResearchCentre for Advancing Health OutcomesTranslational Research in OncologyUniversity of British Columbia
FundersMedical Research CouncilKWF KankerbestrijdingNational Institute for Health and Care ResearchFrancis Crick InstituteCancer Research UKBreast Cancer Research Foundation
KeywordsClinical trialBiomarkerMedicineImmunotherapyWorkflowRisk stratificationOncologyMedical physicsInternal medicineComputer scienceCancerDatabaseBiology

Abstract

fetched live from OpenAlex

Stromal tumor-infiltrating lymphocytes (sTILs) are a potential predictive biomarker for immunotherapy response in metastatic triple-negative breast cancer (TNBC). To incorporate sTILs into clinical trials and diagnostics, reliable assessment is essential. In this review, we propose a new concept, namely the implementation of a risk-management framework that enables the use of sTILs as a stratification factor in clinical trials. We present the design of a biomarker risk-mitigation workflow that can be applied to any biomarker incorporation in clinical trials. We demonstrate the implementation of this concept using sTILs as an integral biomarker in a single-center phase II immunotherapy trial for metastatic TNBC (TONIC trial, NCT02499367), using this workflow to mitigate risks of suboptimal inclusion of sTILs in this specific trial. In this review, we demonstrate that a web-based scoring platform can mitigate potential risk factors when including sTILs in clinical trials, and we argue that this framework can be applied for any future biomarker-driven clinical trial setting.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.075
metaresearch head score (Gemma)0.091
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: none
Teacher disagreement score0.075
Threshold uncertainty score0.397

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0750.091
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0020.004
Bibliometrics0.0050.003
Science and technology studies0.0010.001
Scholarly communication0.0060.003
Open science0.0030.003
Research integrity0.0020.003
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.103
GPT teacher head0.466
Teacher spread0.363 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations19
Published2020
Admission routes1
Has abstractyes

Explore more

Same venuenpj Breast CancerSame topicCancer Immunotherapy and BiomarkersFrench-language works237,207